KRAS and cancer: This mechanism highlights the potential therapeuticstrategy of targeting KRAS to induce cell cycle arrest in cancer cells.50 These combined gene expression changes suggestthat the therapeutic effect of PepGAT and PepKAA may be mediated througha synergistic mechanism involving cell cycle arrest and the activationof apoptotic pathways, presenting a potential strategy for targetedcancer therapy.